PuSH - Publication Server of Helmholtz Zentrum München

231 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
61.
Karo-Atar, D.* et al.: A protective role for IL-13 receptor α 1 in bleomycin-induced pulmonary injury and repair. Mucosal Immunol. 9, 240-253 (2016)
62.
Keller, I.E. et al.: Proteasome-dependent Mhc I antigen presentation is altered by cigarette smoke. Am. J. Respir. Crit. Care Med. 193 (2016)
63.
Knüppel, L. et al.: Effects of nintedanib and pirfenidone on expression and maturation of collagen - A comprehensive analysis. Am. J. Respir. Crit. Care Med. 193 (2016)
64.
Kolahian, S.* ; Fernandez, I.E. ; Eickelberg, O. & Hartl, D.*: Immune mechanisms in pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 55, 309-322 (2016)
65.
Oak, P. et al.: Monocyte-centred inflammatory response characterizing early stages of Bpd development in the preterm infant. Am. J. Respir. Crit. Care Med. 193 (2016)
66.
Pereira, P.R.* et al.: Exercise reduces lung fibrosis involving serotonin/akt signaling. Med. Sci. Sports Exerc. 48, 1276-1284 (2016)
67.
Schamberger, A.C. et al.: Glutathione peroxidase 3 localizes to the epithelial lining fluid and the extracellular matrix in interstitial lung disease. Sci. Rep. 6:29952 (2016)
68.
Schmid, O. et al.: Towards standardized airway hyperresponsiveness measurements In mice. Am. J. Respir. Crit. Care Med. 193:A1351 (2016)
69.
Smirnova, N.F. et al.: Detection and quantification of epithelial progenitor cell populations in human healthy and IPF lungs. Respir. Res. 17:83 (2016)
70.
Staab-Weijnitz, C.A. & Eickelberg, O.: Repositioning compounds from cancer drug discovery to IPF: PI3K inhibition. Thorax 71, 675-676 (2016)
71.
Staab-Weijnitz, C.A. et al.: Expression and regulation of glutathione peroxidase 3 in interstitial lung disease. Am. J. Respir. Crit. Care Med. 193 (2016)
72.
Sun, N. et al.: Pharmacokinetic and pharmacometabolomic study of pirfenidone in normal mouse tissues using high mass resolution MALDI-FTICR-mass spectrometry imaging. Histochem. Cell Biol. 145, 201-211 (2016)
73.
van Rijt, S.H. et al.: Applicability of avidin protein coated mesoporous silica nanoparticles as drug carriers in the lung. Nanoscale 8, 8058-8069 (2016)
74.
Welk, V. et al.: Inhibition of proteasome activity induces formation of alternative proteasome complexes. J. Biol. Chem. 291, 13147-13159 (2016)
75.
Welk, V. ; Semren, N. ; Korfei, M.* ; Günther, A.* & Eickelberg, O.: Proteasome activator 200 (pa200) is dysregulated in fibrotic remodeling of the lung. Am. J. Respir. Crit. Care Med. 193 (2016)
76.
White, E.S.* et al.: An american thoracic society official research statement: Future directions in lung fibrosis research. Am. J. Respir. Crit. Care Med. 193, 792-800 (2016)
77.
Wuttke, S.* et al.: Validating metal-organic framework nanoparticles for their nanosafety in diverse biomedical applications. Adv. Healthc. Mater. 6:1600818 (2016)
78.
Yaroshenko, A.* et al.: Visualization of neonatal lung injury associated with mechanical ventilation using X-ray dark-field radiography. Sci. Rep. 6:24269 (2016)
79.
Zensen, C.* ; Buelvas, I. ; Eickelberg, O. ; Lohmueller, T.* & Feldmann, J.*: 'Optical shaking' of red blood cells: A strategy to measure cell-fluid coupling with optical tweezers. Biophys. J. 110, 134A (2016)
80.
Barapatre, N. et al.: Quantitative detection of drug dose and spatial distribution in the lung revealed by Cryoslicing Imaging. J. Pharm. Biomed. Anal. 102, 129-136 (2015)